Download Docs
Export
Print

SPARX

87909928 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed May 7, 2018
Serial No. 87909928
Examining Attorney RACHEL ARRISON
Interlocutory Attorney ANDREW P BAXLEY
Class Biological preparations for the treatment of cancer using polypeptides and genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors; pharmaceutical preparations for immunotherapy using polypeptides and genetically engineered cells; pharmaceutical preparations for immune cell therapy using polypeptides and genetically engineered cells; 006; 018; 044; 046; 051; 052
SPARX
Case Type Trademark
Status Abandoned after an inter partes decision by the Trademark Trial and Appeal Board. For further information, see TTABVUE on the Trademark Trial and Appeal Board web page.
Opposition 91289285
Spark Therapeutics, Inc. v. Arcellx, Inc.
  • Arcellx, Inc.;
  • Spark Therapeutics, Inc.;
Last Updated: 8 months, 2 weeks ago
Filing Date # Docket Text